Partial Prostate Salvage High Dose Rate Brachytherapy

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexMale
Age45+
SponsorBritish Columbia Cancer Agency

About this trial

A dose-response relationship for radiation in the management of prostate cancer is well established. Local recurrence of prostate cancer after external beam radiotherapy occurs in at least 40% of patients treated because of inability to deliver sufficient dose through external beam techniques. These patients respond well to re-irradiation using brachytherapy with about 50% of selected patients remaining free of recurrence 5 years after salvage. Advanced imaging using multiparametric Magnetic Resonance Imaging (mpMRI) allows identification of the site of recurrence, permitting partial prostate salvage brachytherapy. There is extensive literature on Low Dose Rate salvage brachytherapy but less on High Dose Rate.

Eligibility criteria

Qualifiers

Age >45 and Life expectancy >10 years

Previous External Beam Radiotherapy (EBRT) or LDR brachytherapy w

> 3 year interval since EBRT or LDR Brachytherapy

No late toxicity from prior EBRT ≥ grade 2

Disqualifiers

Not compliant with criteria above

Unable to give informed consent

Trial design

Treatments tested in this trial

  • HDR partial prostate brachytherapy

Treatment groups

30 Participants
are divided into 1 treatment group

Sponsors and collaborators